Historical record - last NADAC effective date: 7/17/2024
Product Information
CHOLESTYRAMINE PACKET is a generic product labeled by TAGI Pharma Inc., priced at $0.6370 per EA under NDC 51224001120. Its NADAC has been published 112 times since Jun 29, 2022.
FDA first approved this application on Mar 9, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
4 g/8.3g
Manufacturer
TAGI Pharma Inc.NDC
51224001120
Classification
Generic
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Effective Date
7/17/2024
Active Ingredients
CHOLESTYRAMINEApproval Type
Generic (ANDA)
FDA Application
ANDA209597FDA Approved
3/9/2021
TE Code
AB
On Market Since
3/10/2021
Pharmacological Classes
Price Statistics
The NADAC for CHOLESTYRAMINE PACKET has been published 112 times since Jun 29, 2022, and over the history we have for it it has declined 42.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6370 per EA |
|---|---|
| All-time high | $1.1213 (Aug 10, 2022) |
| All-time low | $0.5806 (Apr 17, 2024) |
| Median price | $0.8997 |
| Average price | $0.8733 |
| Largest weekly change | +34.2% (Jun 19, 2024) |
| Weeks tracked | 112 |
| Tracking since | Jun 29, 2022 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-29.4%
5Y
N/A
All
-42.5%
Last surveyed Aug 14, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CHOLESTYRAMINE PACKET?
The current National Average Drug Acquisition Cost (NADAC) for CHOLESTYRAMINE PACKET, manufactured by TAGI Pharma Inc., is $0.6370 per EA (NDC 51224001120), effective Aug 14, 2024.
How has the price of CHOLESTYRAMINE PACKET changed over time?
Over the history we have for it, the NADAC for CHOLESTYRAMINE PACKET has declined 42.5%. It has been tracked across 112 weekly CMS publications since Jun 29, 2022.
What are the highest and lowest recorded NADAC prices for CHOLESTYRAMINE PACKET?
Since Jun 29, 2022, the NADAC for CHOLESTYRAMINE PACKET has ranged from a low of $0.5806 (Apr 17, 2024) to a high of $1.1213 (Aug 10, 2022), with a median of $0.8997 per EA.
Are there cheaper alternatives to CHOLESTYRAMINE PACKET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CHOLESTYRAMINE PACKET in a comparable dosage form, but none are currently priced below it.
Who manufactures CHOLESTYRAMINE PACKET?
CHOLESTYRAMINE PACKET (NDC 51224001120) is labeled by TAGI Pharma Inc., and CMS classifies it as a generic product.